Six-Color Multiplex Digital PCR Assays for Comprehensive Screening and Identification of Multiple Driver Mutations Associated with Pancreatic Carcinogenesis
Clinical Chemistry · 2026
DOI: 10.1093/clinchem/hvaf181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry, 2026. Verfasst von Chiho Maeda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Bioinformatics, Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Multiplex Polymerase Chain Reaction, Mutation, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hitachi High-Tech Corporation, Japan Society for the Promotion of Science, Princess Takamatsu Cancer Research Fund.
Abstract (Originalsprache)
Background
Digital polymerase chain reaction (dPCR) is widely recognized for its high sensitivity in detecting low-frequency variants; however, conventional 2-color systems have limited multiplex capacity. Expanding this capability is essential for simultaneous detection of multiple driver mutations in cancer-related genes. KRAS and GNAS are key driver genes in the early development of pancreatic cancer and its precursor lesions, and mutations in these genes are often present at low abundance in clinical samples.
Methods
Two 6-color dPCR assays were developed using a droplet-based platform. PlexScreen-dPCR is a multicolored drop-off assay designed to screen for mutations in KRAS codons 12/13 and 61 and GNAS codon 201, without specifying individual variants. PlexID-dPCR employs variant-specific probes to distinguish among 14 predefined KRAS and GNAS mutations in a single reaction. The assays were validated using synthetic DNA, cell lines, 23 tissue samples, and 12 duodenal fluid samples. Customized primer/probe sets with 6 fluorophores were employed in a 6-color droplet dPCR system, and the limits of detection (LOD) were determined.
Results
PlexScreen-dPCR, applied in contrived samples, demonstrated LODs as low as 0.03% to 0.06%, enabling high-sensitivity detection of low-abundance mutations. PlexID-dPCR accurately identified all 14 variants in a single well. Both assays showed complete concordance with conventional methods, exhibiting a strong correlation for variant allele frequency quantification.
Conclusions
These 6-color dPCR assays offer scalable solutions for improved throughput detection of KRAS and GNAS mutations. Their compatibility with commercially available platforms and streamlined workflow support their integration into clinical practice. Further optimization can enhance cluster interpretation in high-plex settings and facilitate expansion toward broader genomic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Bioinformatics, Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
- Department of Advanced Genomic Community Healthcare, Asahikawa Medical University, Asahikawa, Japan.
- Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
- Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
ORCID-Profile: Yusuke Ono, Kenji Takahashi
Förderung
- Hitachi High-Tech Corporation
- Japan Society for the Promotion of Science
- Princess Takamatsu Cancer Research Fund
- the Naito Grant for the Advancement of Natural Science
- Project Mirai Cancer Research Grants
Zitieren
APA
Maeda, C., Ono, Y., Takahashi, K., Mori, M., Suzuki, M., Tamamura, N., Sun, Y., Itoh, T., Tanaka, H., Kawabata, H., Okada, T., Koyama, K., Ohtaki, Y., Omori, Y., Yamamoto, T., & Mizukami, Y. (2026). Six-Color Multiplex Digital PCR Assays for Comprehensive Screening and Identification of Multiple Driver Mutations Associated with Pancreatic Carcinogenesis. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvaf181
Vancouver
Maeda C, Ono Y, Takahashi K, Mori M, Suzuki M, Tamamura N, et al. Six-Color Multiplex Digital PCR Assays for Comprehensive Screening and Identification of Multiple Driver Mutations Associated with Pancreatic Carcinogenesis. Clinical Chemistry. 2026. doi:10.1093/clinchem/hvaf181
BibTeX
@article{Maeda2026,
author = {Maeda, Chiho and Ono, Yusuke and Takahashi, Kenji and Mori, Miyuki and Suzuki, Mayumi and Tamamura, Nobue and Sun, Yanpeng and Itoh, Taito and Tanaka, Hiroki and Kawabata, Hidemasa and Okada, Tetsuhiro and Koyama, Kazuya and Ohtaki, Yu and Omori, Yuko and Yamamoto, Takuya and Mizukami, Yusuke},
title = {Six-Color Multiplex Digital PCR Assays for Comprehensive Screening and Identification of Multiple Driver Mutations Associated with Pancreatic Carcinogenesis},
journal = {Clinical Chemistry},
year = {2026},
doi = {10.1093/clinchem/hvaf181}
}
EUVIMED